# CEBPB

## Overview
CEBPB is a gene that encodes the CCAAT/enhancer-binding protein beta (C/EBPβ), a transcription factor belonging to the basic leucine zipper (bZIP) family. This protein plays a pivotal role in regulating gene expression across various biological processes, including immune response, inflammation, metabolism, and cellular differentiation. C/EBPβ is characterized by its ability to form homo- or heterodimers, which are essential for its DNA-binding and transcriptional activities (Greene2023Targeting). The protein is involved in critical cellular functions such as macrophage activation, adipogenesis, and synaptic plasticity, highlighting its versatility and importance in maintaining cellular homeostasis (RAMJI2002CCAATenhancerbinding). Additionally, C/EBPβ's interactions with other proteins and its response to post-translational modifications underscore its regulatory complexity and its potential implications in various diseases, including Alzheimer's disease and anaplastic large cell lymphoma (Piva2006Functional; Yao2021A).

## Structure
The CEBPB gene encodes a transcription factor that is part of the basic leucine zipper (bZIP) family, characterized by a basic DNA-binding region followed by a leucine zipper domain. This structure facilitates the formation of homo- or heterodimers, which are essential for DNA binding and transcriptional activity (Greene2023Targeting). The bZIP domain is crucial for DNA binding and dimerization, with the DNA binding domain containing a basic region that interacts directly with DNA nucleotides. A notable feature is the presence of a valine at position 285, which influences the protein's binding affinity to methylated DNA (Ray2019The).

CEBPB can undergo post-translational modifications, such as phosphorylation, which significantly affect its conformation and function. Phosphorylation at specific sites can induce conformational changes that alter its activity, with different phosphorylation patterns observed in ancestral therian and eutherian CEBPB proteins (Lynch2011Regulatory). The protein is expressed in multiple isoforms due to alternative translation initiation sites, which may lack functional transactivation domains, impacting their activity (Akasaka2006Five). These structural and functional characteristics underscore the complexity and regulatory versatility of CEBPB in cellular processes.

## Function
The CEBPB gene encodes the CCAAT/enhancer-binding protein beta (C/EBPβ), a transcription factor that plays a significant role in various cellular processes in healthy human cells. C/EBPβ is involved in the regulation of gene expression related to immune response, inflammation, and metabolism. It is crucial for the activation and differentiation of macrophages, influencing immune responses by regulating cytokine production and promoting an anti-inflammatory M2 macrophage phenotype, which is essential for muscle repair and regeneration following injury (Blackwell2014Changes; RAMJI2002CCAATenhancerbinding).

C/EBPβ is also involved in adipogenesis, where it regulates the differentiation of pre-adipocytes into adipocytes by inducing the expression of other transcription factors such as C/EBPα and PPARγ, which are critical for terminal adipocyte differentiation (Armanmehr2022Analysis; RAMJI2002CCAATenhancerbinding). In the context of metabolism, C/EBPβ helps fine-tune responses to nutritional changes, affecting glucose production and lipid metabolism (RAMJI2002CCAATenhancerbinding).

In the nervous system, C/EBPβ is implicated in long-term synaptic plasticity and memory consolidation, with its expression and activity enhanced in hippocampal neurons by cAMP and calcium (RAMJI2002CCAATenhancerbinding). C/EBPβ is active in the nucleus, where it binds to specific DNA sequences, influencing the transcription of target genes and modulating cellular functions in response to various stimuli (RAMJI2002CCAATenhancerbinding).

## Clinical Significance
Alterations in the expression and interactions of the CEBPB gene have been implicated in several diseases, including Alzheimer's disease and anaplastic large cell lymphoma (ALCL). In Alzheimer's disease, a delta-secretase-truncated fragment of the amyloid precursor protein (APP), known as APP C586-695, interacts with CEBPB, enhancing its transcriptional activity. This interaction leads to the upregulation of Alzheimer's disease-related genes, contributing to amyloid-beta production, neuro-inflammation, and synaptic reduction, which are associated with cognitive deficits (Yao2021A). The presence of Fe65 is crucial for the APP C586-695 fragment's effect on CEBPB's transcriptional activity, suggesting that targeting this interaction could be a potential therapeutic approach (Yao2021A).

In ALCL, particularly ALK-positive cases, CEBPB is strongly expressed and is crucial for cell survival and proliferation. It is regulated by the anaplastic lymphoma kinase (ALK) signaling pathway, and its expression is necessary for NPM-ALK-mediated transformation. Silencing CEBPB in ALK-positive cell lines leads to increased apoptosis, indicating its importance in the pathogenesis of ALCL (Piva2006Functional). These findings highlight the role of CEBPB in both neurodegenerative and oncogenic processes.

## Interactions
CEBPB (CCAAT enhancer binding protein beta) is a transcription factor that participates in various protein-protein and protein-DNA interactions, playing a crucial role in gene regulation. CEBPB forms heterodimers with other B-ZIP family proteins, including ATF4, FOS, JUN, and ATF2, which influences its DNA binding specificity and regulatory functions (Vinson2002Classification). The CEBPB|ATF4 heterodimer specifically binds to methylated DNA sequences, such as CGAT|GCAA, with increased affinity, highlighting the impact of DNA methylation on its binding properties (Mann2013CG).

In the context of cellular stress responses, CEBPB interacts with ATF4, a key regulator, and is involved in processes like protein amino acid phosphorylation, which is important for signaling pathways that inhibit protein biosynthesis following ER stress (Mann2013CG). CEBPB also associates with the leucine zipper protein CHOP under mitochondrial stress conditions and heterodimerizes with CEBPG, which is implicated in promoting cell proliferation and is considered a probable oncogene in various cancers (Greene2023Targeting).

CEBPB's interaction with nucleic acids includes binding to specific DNA sequences, such as the canonical CEBP motif and methylated sequences, which are associated with different cellular functions, including transcription regulation and cell motility (Mann2013CG). These interactions underscore CEBPB's role in modulating gene expression and cellular responses to environmental cues.


## References


[1. (Greene2023Targeting) Lloyd A. Greene, Qing Zhou, Markus D. Siegelin, and James M. Angelastro. Targeting transcription factors atf5, cebpb and cebpd with cell-penetrating peptides to treat brain and other cancers. Cells, 12(4):581, February 2023. URL: http://dx.doi.org/10.3390/cells12040581, doi:10.3390/cells12040581. This article has 9 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cells12040581)

[2. (Vinson2002Classification) Charles Vinson, Max Myakishev, Asha Acharya, Alain A. Mir, Jonathan R. Moll, and Maria Bonovich. Classification of human b-zip proteins based on dimerization properties. Molecular and Cellular Biology, 22(18):6321–6335, September 2002. URL: http://dx.doi.org/10.1128/mcb.22.18.6321-6335.2002, doi:10.1128/mcb.22.18.6321-6335.2002. This article has 348 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/mcb.22.18.6321-6335.2002)

[3. (Ray2019The) Sreejana Ray, Aniekanabasi Ufot, Nima Assad, Jocelyn Singh, Stewart R. Durell, Aleksey Porollo, Desiree Tillo, and Charles Vinson. The bzip mutant cebpb (v285a) has sequence specific dna binding propensities similar to creb1. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 1862(4):486–492, April 2019. URL: http://dx.doi.org/10.1016/j.bbagrm.2019.02.002, doi:10.1016/j.bbagrm.2019.02.002. This article has 4 citations.](https://doi.org/10.1016/j.bbagrm.2019.02.002)

[4. (Lynch2011Regulatory) Vincent J. Lynch, Gemma May, and Günter P. Wagner. Regulatory evolution through divergence of a phosphoswitch in the transcription factor cebpb. Nature, 480(7377):383–386, November 2011. URL: http://dx.doi.org/10.1038/nature10595, doi:10.1038/nature10595. This article has 95 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/nature10595)

[5. (Blackwell2014Changes) Jamie Blackwell, Lorna W. Harries, Luke C. Pilling, Luigi Ferrucci, Andrew Jones, and David Melzer. Changes in cebpb expression in circulating leukocytes following eccentric elbow-flexion exercise. The Journal of Physiological Sciences, 65(1):145–150, November 2014. URL: http://dx.doi.org/10.1007/s12576-014-0350-7, doi:10.1007/s12576-014-0350-7. This article has 11 citations.](https://doi.org/10.1007/s12576-014-0350-7)

[6. (Armanmehr2022Analysis) Azam Armanmehr, Hossein Jafari Khamirani, Sina Zoghi, and Mehdi Dianatpour. Analysis of dyrk1b, pparg, and cebpb expression patterns in adipose-derived stem cells from patients carrying dyrk1b r102c and healthy individuals during adipogenesis. Metabolic Syndrome and Related Disorders, 20(10):576–583, December 2022. URL: http://dx.doi.org/10.1089/met.2021.0140, doi:10.1089/met.2021.0140. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.1089/met.2021.0140)

[7. (Yao2021A) Yinan Yao, Seong Su Kang, Yiyuan Xia, Zhi-Hao Wang, Xia Liu, Thorsten Muller, Yi E Sun, and Keqiang Ye. A delta-secretase-truncated app fragment activates cebpb, mediating alzheimer’s disease pathologies. Brain, 144(6):1833–1852, April 2021. URL: http://dx.doi.org/10.1093/brain/awab062, doi:10.1093/brain/awab062. This article has 23 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1093/brain/awab062)

[8. (Akasaka2006Five) Takashi Akasaka, Theodore Balasas, Lisa J. Russell, Kei-ji Sugimoto, Aneela Majid, Renata Walewska, E. Loraine Karran, David G. Brown, Kelvin Cain, Lana Harder, Stefan Gesk, Jose Ignacio Martin-Subero, Mark G. Atherton, Monika Brüggemann, María José Calasanz, Teresa Davies, Oskar A. Haas, Anne Hagemeijer, Helena Kempski, Michel Lessard, Debra M. Lillington, Sarah Moore, Florence Nguyen-Khac, Isabelle Radford-Weiss, Claudia Schoch, Stéphanie Struski, Polly Talley, Melanie J. Welham, Helen Worley, Jon C. Strefford, Christine J. Harrison, Reiner Siebert, and Martin J. S. Dyer. Five members of the cebp transcription factor family are targeted by recurrent igh translocations in b-cell precursor acute lymphoblastic leukemia (bcp-all). Blood, 109(8):3451–3461, December 2006. URL: http://dx.doi.org/10.1182/blood-2006-08-041012, doi:10.1182/blood-2006-08-041012. This article has 159 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1182/blood-2006-08-041012)

[9. (Mann2013CG) Ishminder K. Mann, Raghunath Chatterjee, Jianfei Zhao, Ximiao He, Matthew T. Weirauch, Timothy R. Hughes, and Charles Vinson. Cg methylated microarrays identify a novel methylated sequence bound by the cebpb|atf4 heterodimer that is active in vivo. Genome Research, 23(6):988–997, April 2013. URL: http://dx.doi.org/10.1101/gr.146654.112, doi:10.1101/gr.146654.112. This article has 115 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1101/gr.146654.112)

[10. (Piva2006Functional) Roberto Piva, Elisa Pellegrino, Michela Mattioli, Luca Agnelli, Luigia Lombardi, Francesco Boccalatte, Giulia Costa, Bruce A. Ruggeri, Mangeng Cheng, Roberto Chiarle, Giorgio Palestro, Antonino Neri, and Giorgio Inghirami. Functional validation of the anaplastic lymphoma kinase signature identifies cebpb and bcl2a1 as critical target genes. Journal of Clinical Investigation, 116(12):3171–3182, December 2006. URL: http://dx.doi.org/10.1172/jci29401, doi:10.1172/jci29401. This article has 128 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1172/jci29401)

[11. (RAMJI2002CCAATenhancerbinding) Dipak P. RAMJI and Pelagia FOKA. Ccaat/enhancer-binding proteins: structure, function and regulation. Biochemical Journal, 365(3):561–575, August 2002. URL: http://dx.doi.org/10.1042/bj20020508, doi:10.1042/bj20020508. This article has 1060 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1042/bj20020508)